Clinical trials recruiting for Psoriatic arthritis
45
Recruiting trials
37
US states with sites
40
Countries
9%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 11 |
| Florida | 10 |
| Texas | 10 |
| Ohio | 9 |
| Pennsylvania | 8 |
| Maryland | 7 |
| Arizona | 6 |
| Illinois | 6 |
| New York | 6 |
| Tennessee | 6 |
| Georgia | 5 |
| Michigan | 5 |
Top cities
Houston, Texas 8Middleburg Heights, Ohio 5Duncansville, Pennsylvania 4Hagerstown, Maryland 4Jackson, Tennessee 4Philadelphia, Pennsylvania 4Tampa, Florida 4Tucson, Arizona 4Baltimore, Maryland 3Baytown, Texas 3
Self-screener
Recruiting trials
- A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
- A Study of Picankibart in Patients With Active Psoriatic Arthritis
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
- A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Biobank for Inflammatory Chronic Diseases and Osteoporosis
- Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient
- Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
- Cytokine Expression in Psoriasis Patients With and Without Joint Involvement
- Deployment o the Multidisciplinary Prospective Cohort Imminent
- Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
- Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
- Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
- Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist
- Evolution and Treatments of Chronic Inflammatory Systemic Diseases
- Genetic Variation in TRAF3IP2 (rs13190932)
- Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- HIPPOCRATES Prospective Observational Study
- HLA B Leader in Patients With Psoriatic Arthritis
- INSELMA - a Randomised Controlled Trial
- Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic Arthritis
- Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons
- Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy
- Korean College of Rheumatology Biologics and Targeted Therapy Registry
- Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
- Modifying PEST for Psoriatic Arthritis Screening
- Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
- PsoBest - The German Psoriasis Registry
- Rheumatology Diet Study
- Rheumatology Patient Registry and Biorepository
- Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
- Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- Stronger Together Psoriatic Arthritis Wellness Study
- Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- Transcutaneous Auricular Vagus Nerve Stimulation in Psoriatic Arthritis
- WORK-ON Vocational Rehabilitation for People with Inflammatory Arthritis
Related conditions
Trials recruiting for Psoriatic arthritis often also study these conditions. Each links to its own recruiting-trial list.
Psoriasis 233Rheumatoid arthritis 314Lupus 332Systemic lupus erythematosus 119Ankylosing Spondylitis 12Crohn's disease 328Ulcerative colitis 288Axial Spondyloarthritis 6Systemic Sclerosis 27Sjogren's Syndrome 25
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Psoriatic arthritis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.